Inventor · disambiguated record
Todd C. Zankel
Also filed as: ZANKEL TODD · ZANKEL TODD C
16 granted patents·13 pending applications·136 citations·filing 2003–2024
93Inventor score
Files withHORIZON ORPHAN LLC7MERCAPTOR DISCOVERIES INC4STARR CHRISTOPHER M4RAPTOR PHARMACEUTICAL INC3ZANKEL TODD C3
Top patents by PatentIndex Score
29 records- 0196US8546319B2Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymesSTARR CHRISTOPHER M·Filed 2010·Granted Oct 1, 2013·25 cites·10 claims
- 0292US8877714B2Compositions comprising receptor-associated protein (RAP) variants specific for LRP2 and uses thereofSTARR CHRISTOPHER M·Filed 2006·Granted Nov 4, 2014·12 cites·25 claims
- 0391US7560431B2Methods of increasing delivery of active agents to brain comprising administering receptor associated protein (RAP) fragments conjugated to active agentsRAPTOR PHARMACEUTICAL INC·Filed 2005·Granted Jul 14, 2009·16 cites·12 claims
- 0490US7569544B2Methods of increasing delivery of active agents to brain comprising administering receptor associated protein (RAP) fragments conjugated to active agentsRAPTOR PHARMACEUTICAL INC·Filed 2004·Granted Aug 4, 2009·29 cites·12 claims
- 0587US9062126B2Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereofZANKEL TODD C·Filed 2006·Granted Jun 23, 2015·11 cites·47 claims
- 0687US8795627B2Treatment of liver disorders by administration of RAP conjugatesSTARR CHRISTOPHER M·Filed 2007·Granted Aug 5, 2014·12 cites·27 claims
- 0786US8440629B2Cyclic receptor-associated protein (RAP) peptidesSTARR CHRISTOPHER M·Filed 2008·Granted May 14, 2013·10 cites·20 claims
- 0886US7829537B2Receptor associated protein (RAP) conjugatesRAPTOR PHARMACEUTICALS INC·Filed 2009·Granted Nov 9, 2010·6 cites·13 claims
- 0983US9951013B2Fucosidase inhibitorsHORIZON ORPHAN LLC·Filed 2016·Granted Apr 24, 2018·7 cites·24 claims
- 1082US10906904B2ADO-resistant cysteamine analogs and uses thereofHORIZON ORPHAN LLC·Filed 2016·Granted Feb 2, 2021·2 cites·4 claims
- 1179US8609103B2Megalin-based delivery of therapeutic compounds to the brain and other tissuesZANKEL TODD C·Filed 2010·Granted Dec 17, 2013·3 cites·17 claims
- 1275US2025177330A1Use of Thiol Compounds to Treat Neurological DiseaseMERCAPTOR DISCOVERIES INC·Filed 2024·Application pending·0 cites
- 1374US10308607B2Fucosidase inhibitorsHORIZON ORPHAN LLC·Filed 2018·Granted Jun 4, 2019·2 cites·14 claims
- 1474US2020188522A1Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymesBIOASIS TECHNOLOGIES INC·Filed 2019·Application pending·0 cites
- 1572US9879064B2Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereofHORIZON ORPHAN LLC·Filed 2015·Granted Jan 30, 2018·1 cites·12 claims
- 1669US12128014B2Use of thiol compounds to treat neurological diseaseMERCAPTOR DISCOVERIES INC·Filed 2022·Granted Oct 29, 2024·0 cites·3 claims
- 1769US10716862B2Use of P97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymesBIOASIS TECHNOLOGIES INC·Filed 2017·Granted Jul 21, 2020·0 cites·3 claims
- 1869US2014105880A1Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymesBIOASIS ADVANCED TECHNOLOGIES INC·Filed 2013·Application pending·0 cites
- 1967US11505550B2ADO-resistant cysteamine analogs and uses thereofHORIZON ORPHAN LLC·Filed 2021·Granted Nov 22, 2022·0 cites·2 claims
- 2059US2005158296A1Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymesFiled 2003·Application pending·0 cites
- 2158US2021069129A1Use of Thiol Compounds to Treat Neurological DiseaseMERCAPTOR DISCOVERIES INC·Filed 2020·Application pending·0 cites
- 2258US2009191178A1Manufacture of Highly Phosphorylated Lysosomal Enzymes and Uses ThereofBIOMARIN PHARM INC·Filed 2008·Application pending·0 cites
- 2358US2019029977A1Use of Thiol Compounds to Treat Neurological DiseaseMERCAPTOR DISCOVERIES INC·Filed 2018·Application pending·0 cites
- 2456US2005026823A1Use of the chaperone receptor-associated protein (RAP) for the delivery of therapeutic compounds to the brain and other tissuesBIOMARIN PHARM INC·Filed 2003·Application pending·0 cites
- 2554US2018118802A1Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereofHORIZON ORPHAN LLC·Filed 2017·Application pending·0 cites
- 2647US2008014188A1Manufacture of Highly Phosphorylated Lysosomal Enzymes and Uses ThereofZANKEL TODD C·Filed 2005·Application pending·0 cites
- 2747US2021113496A1Methods of Treating Excitotoxicity DisordersHORIZON ORPHAN LLC·Filed 2019·Application pending·0 cites
- 2844US2015125526A1Use of Cysteamine and Derivatives Thereof to Treat Mitochondrial DiseasesRAPTOR PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2936US2011189084A1Method for Treating Liver Disorders with Receptor Associated Protein (RAP) Peptide-Fucosidase Inhibitor ConjugatesRAPTOR PHARMACEUTICAL INC·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Todd C. Zankel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →